OnCore Login

Return to Trial Database

MMP-MEL18-372

Phase 1B/2 Study of PAC-1 and Entrectinib for Patients with Metastatic Uveal Melanoma

 

Status

Study Completed

Cancer Type(s)

Melanoma

Study Contact

Publications

The combination of PAC-1 and entrectinib for the treatment of metastatic uveal melanoma
  • M Boudreau, E Tonogai, C Schane, MX Xi, J Fischer, J Vijayakumar, Y Ji, T Tarasow, T Fan, P Hergenrother, A Dudek

Trial Locations

All sites in which the trial MMP-MEL18-372 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278